Impact of atherosclerotic cardiovascular disease on healthcare resource utilization and costs in patients with type 2 diabetes mellitus in a real-world setting

Impact of atherosclerotic cardiovascular disease on healthcare resource utilization and costs in patients with type 2 diabetes mellitus in a real-world setting

Abstract Background This study evaluated the impact of atherosclerotic cardiovascular disease (ASCVD) on healthcare resource utilization and costs in patients with type 2 diabetes mellitus (T2DM). Methods This study was a retrospective, cross-sectional study using US claims data. Adult patients with...

Full description

Bibliographic Details
Main Authors:	Wayne Weng, Ye Tian, Sheldon X. Kong, Rahul Ganguly, Malene Hersloev, Jason Brett, Todd Hobbs
Format:	Article
Language:	English
Published:	BMC 2020-03-01
Series:	Clinical Diabetes and Endocrinology
Subjects:	Atherosclerotic cardiovascular disease Type 2 diabetes mellitus Healthcare utilization Cost Real-world Claims
Online Access:	http://link.springer.com/article/10.1186/s40842-019-0090-y

Similar Items

The prevalence of cardiovascular disease and antidiabetes treatment characteristics among a large type 2 diabetes population in the United States
by: Wayne Weng, et al.
Published: (2019-07-01)

The prevalence of cardiovascular disease by vascular bed and impact on healthcare costs in a large, real‐world population with type 2 diabetes
by: Wayne Weng, et al.
Published: (2020-04-01)

Lycopene‐whey complex (bioavailable lycopene) and risk of atherosclerotic plaques Scientific substantiation of a health claim related to Lycopene‐whey complex (bioavailable lycopene) and reduction of the risk of atherosclerotic plaques pursuant to Article 14 of Regulation (EC) No 1924/2006
by: European Food Safety Authority (EFSA)
Published: (2009-08-01)

Hospital healthcare utilizers with medical and psychiatric claims in the Netherlands: a nationwide study
by: Maarten van Schijndel, et al.
Published: (2022-04-01)

Characteristics of Treated Asthmatics Experiencing Exacerbations in a US Database: A Retrospective Cohort Study
by: Averell CM, et al.
Published: (2021-07-01)

Impact of Elexacaftor/Tezacaftor/Ivacaftor on Healthcare Resource Utilization and Associated Costs Among People With Cystic Fibrosis in the US: A Retrospective Claims Analysis
by: Michael S. Schechter, et al.
Published: (2023-10-01)

Healthcare resource utilization and costs in 23–25-year-old women with human papillomavirus (HPV) associated anogenital diseases in Germany – a retrospective analysis of statutory health insurance claims data
by: Miriam Reuschenbach, et al.
Published: (2022-08-01)

Fibrinogen and Atherosclerotic Cardiovascular Diseases—Review of the Literature and Clinical Studies
by: Stanisław Surma, et al.
Published: (2021-12-01)

Real-World Reductions in Oral Corticosteroid Use in the USA Following Mepolizumab Therapy for Severe Asthma
by: Silver J, et al.
Published: (2020-12-01)

Atherosclerotic Plaque Characterization Methods Based on Coronary Imaging /
by: Athanasiou, Lambros S., author 649677, et al.
Published: (2017)

Evaluating the relationship between clinical and demographic characteristics of insulin-using people with diabetes and their health outcomes: a cluster analysis application
by: Elizabeth L. Eby, et al.
Published: (2021-07-01)

Association of Hypertriglyceridemia with All‐Cause Mortality and Atherosclerotic Cardiovascular Events in a Low‐Risk Italian Population: The TG‐REAL Retrospective Cohort Analysis
by: Marcello Arca, et al.
Published: (2020-10-01)

Gaps in Evidence‐Based Therapy Use in Insured Patients in the United States With Type 2 Diabetes Mellitus and Atherosclerotic Cardiovascular Disease
by: Adam J. Nelson, et al.
Published: (2021-01-01)

Incidence of cancers in patients with atherosclerotic cardiovascular diseases
by: Makoto Suzuki, et al.
Published: (2017-12-01)

Spectral Differences Between Normal and Atherosclerotic Aorta
by: Nikolay Korovin
Published: (2020-12-01)

10-YEAR RISK ESTIMATION OF ATHEROSCLEROTIC CARDIOVASCULAR DISEASE IN HYPERTENSIVE PATIENTS
by: Olha M. Chernatska, et al.
Published: (2021-06-01)

HbA1c as indicator for dyslipidaemia, cardiovascular and atherosclerotic events in patients with metabolic syndrome
by: Haider Alyasiri
Published: (2019-05-01)

HbA1c as indicator for dyslipidaemia, cardiovascular and atherosclerotic events in patients with metabolic syndrome
by: Haider Alyasiri
Published: (2019-05-01)

HbA1c as indicator for dyslipidaemia, cardiovascular and atherosclerotic events in patients with metabolic syndrome
by: Haider Alyasiri
Published: (2019-05-01)

Healthcare resource utilization, costs and treatment associated with myasthenia gravis exacerbations among patients with myasthenia gravis in the USA: a retrospective analysis of claims data
by: Julia Pisc, et al.
Published: (2023-12-01)

The contribution of arterial ultrasound scanning to atherosclerotic cardiovascular risk stratification: Short review
by: Andrew N Nicolaides, et al.
Published: (2023-01-01)

Research Landscape on Atherosclerotic Cardiovascular Disease and Inflammation: A Bibliometric and Visualized Study
by: Wende Tian, et al.
Published: (2022-09-01)

Prevalence and incidence of atherosclerotic cardiovascular disease and its risk factors in Korea: a nationwide population-based study
by: Hyungtae Kim, et al.
Published: (2019-08-01)

Genetic Predisposition of Atherosclerotic Cardiovascular Disease in Ancient Human Remains
by: Christina Wurst, et al.
Published: (2024-01-01)

Penetrating Atherosclerotic Aortic Ulcer
by: Walsh, Ryan, et al.
Published: (2010-12-01)

Exploring Contemporary Data on Lipid-Lowering Therapy Prescribing in Patients Following Discharge for Atherosclerotic Cardiovascular Disease in the South of Italy
by: Anna Citarella, et al.
Published: (2022-07-01)

Inhibitors in the Management of Patients with Atherosclerotic Cardiovascular Diseases: Guidelines and Reimbursement Issues
by: M. V. Zhuravleva, et al.
Published: (2020-09-01)

Pathways by Which Food Insecurity Is Associated With Atherosclerotic Cardiovascular Disease Risk
by: Deepak Palakshappa, et al.
Published: (2021-11-01)

Geographic variation in hospital costs, payments, and length of stay for opioid-related hospital visits in the USA
by: Mallow PJ, et al.
Published: (2018-12-01)

Current smoking is associated with extracranial carotid atherosclerotic stenosis but not with intracranial large artery disease
by: Ruijun Ji, et al.
Published: (2017-06-01)

Machine learning for the prediction of atherosclerotic cardiovascular disease during 3‐year follow up in Chinese type 2 diabetes mellitus patients
by: Jinru Ding, et al.
Published: (2023-11-01)

Moving toward combination lipid-lowering therapy for all patients with atherosclerotic cardiovascular disease
by: Kamil F. Faridi, et al.
Published: (2023-06-01)

Evaluation of treatment patterns, healthcare resource utilization and cost of illness for sickle cell disease in Ghana: a private medical insurance claims database study
by: Kwaku Marfo, et al.
Published: (2023-09-01)

Impact of initiation of amikacin liposome inhalation suspension on hospitalizations and other healthcare resource utilization measures: a retrospective cohort study in real-world settings
by: Timothy Aksamit, et al.
Published: (2022-12-01)

Healthcare Utilization and Prevalence of Symptoms in Women with Menopause: A Real-World Analysis
by: Sharman Moser S, et al.
Published: (2020-06-01)

Routine treatment pathways in a cohort of patients with major depression and suicidality in Italy: the ARIANNA observational study
by: Maurizio Pompili, et al.
Published: (2023-11-01)

Aspirin Dosing for Secondary Prevention of Atherosclerotic Cardiovascular Disease in Patients Treated With P2Y12 Inhibitors
by: Saket Girotra, et al.
Published: (2023-10-01)

Healthcare financing in Croatia
by: Nevenka Kovač
Published: (2013-12-01)

Association between triglyceride-glucose index and intracranial/extracranial atherosclerotic stenosis: findings from a retrospective study
by: Yu Xie, et al.
Published: (2024-03-01)

Age and Aspirin Dosing in Secondary Prevention of Atherosclerotic Cardiovascular Disease
by: Guillaume Marquis‐Gravel, et al.
Published: (2024-02-01)